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ABSTRACT 
Indoles are probably the most widely distributed heterocyclic compound in nature. Tryptophan and essential amino acid as such is constituent 
of most proteins. Starting materials were identified by physical, chromatographic and spectral analysis. For substituted isonitroso acetanilide  
3.6 gm (0.05M) of chloral hydrate and 48 ml of purified water was taken in it. Then 44 gm of crystallized anhydrous sodium sulfate was added 
in it and a solution of substituted aniline (0.05 M) in 12 ml of water with 1.7 ml (0.052M) of concentrated hydrochloric acid was added to 
dissolve the amine, and finally, a solution of 4.5gm (0.158M) of hydroxylamine hydrochloride in 20 ml of water.for preparatio n of  substituted 
isatin from substituted isonitroso acetanilide 32.5 ml of concentrated sulfuric acid was warmed upto 50C in a 100 ml round bottom flask with 
continuous stirring, and 7.5 gram of (0.046 M) of dry substituted isonitroso acetanilide was added to such a rate that to keep the temperature 
60-70 but not higher. All synthesized final products were screened for in vitro antibacterial activity [ 13-19, 20-22] against four bacterial 
strains, namely Staphylococcus aureus (MTCC 96), Staphylococcus pyogenus, Pseudomonas aeruginosa (MTCC 1688), Escherichia coli (MTCC 443) 
and two fungal strains, namely Candida albicans (MTCC 227) and Aspergilla niger (MTCC 282). in-vitro antimicrobial activity with the zone 
Inhibition in mm 24±2 and activity index 0.89, against Staphylococcus aureus, 22±2 and 0.85 against Staphylococcus pyogenes, 26±2 and 0.96 
against Pseudomonas aeruginos, 25±3 and 0.86 against Escherichia coli and two fungal strains shown 26±4 and 0.81 against Candida albicans 
and 14±2 & 0.88 against Aspergilla niger respectively. 
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1. INTRODUCTION: 
Indole and its derivatives have occupied a unique place in the 
chemistry of nitrogen heterocyclic compounds. The indole 
derivatives were known for their dying properties. Many 
compounds of indole derivatives having the structural 
resemblance to the ancient dye indigo are known in the 
literature. A large number of naturally occurring compounds, 
like alkaloids, were found to possess indole nucleus [1, 2, 3-
4]. This synthetic technique is based on the empirical 
observation that some organic reactions proceed much faster 
and with higher yields under microwave irradiation as 
compared to conventional heating. In many cases reactions 
that normally require many hours at reflux temperature 
under classical conditions can be completed within several 
minutes or even seconds in a microwave oven. 
Isatin or 1H-indole-2, 3-dione is an indole derivative (figure 
1). The compound was first obtained by Erdman and Laurent 
in 1841 as a product from the oxidation of indigo dye by 
nitric acid and chromic acids [5]. 
 
Figure 1: Isatin or 1H-indole-2, 3-dione or indole derivative 
1.1 Indole Derivative  
Protonation, nitration, sulfonation, acylation, halogenations, 
formation of various metal complexes etc. It gives 
electrophilic as well as nucleophilic reactions. Indoles are 
probably the most widely distributed heterocyclic compound 
in nature. Tryptophan and essential amino acid as such is 
constituent of most proteins. In animals serotonins (5-HT), 
melatonin are also indole derivatives. These are widely used 
e.g. sumatryptan, for the treatment of migraine, ondansetron 
for the suppression of nausea and alosteron for treatment of 
irritable bowel syndrome. In plant kingdom tryptophan 
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derived substances are also useful e.g., indole-3-yl acetic acid 
is a plant growth hormone. Vincristine, a dimeric indole 
alkaloid is still extremely important in treatment of cancer. 
Brassinin, isolated from turnips is a phytoalexin. It prevents 
plants from microbial attack. The physiological activities of 
LSD are well known and in synthetic field use of 
indomethacin in treatment of rheumatoidarthritis explains 
why indole and its derivatives is still a very interesting 
molecule since its synthesis in 1866. [6-10]. 
2. MATERIALS & METHOD 
Starting materials were identified by physical, 
chromatographic and spectral analysis. The chemical 
structures of the synthesized compounds were established 
on the basis of physical, chemical, analytical data. The 
purification of the compounds was carried by purification 
methods like recrystallization. Physical constant like melting 
point, boiling point etc, of the new compounds were 
determined. The purity and progress of the reactions were 
monitored by TLC, and column chromatography (if needed) 
by using suitable solvents and UV, FTIR, NMR, CHN analysis 
and MASS spectral data were used for the characterization of 
the synthesized compounds by sending the sample to various 
advanced research laboratory. 
2.1 Identification of Starting Materials:  
2.1.1 Physical appearance:  
Starting materials were inspected visually for physical 
appearance. It was physically characterized on the basis of 
organoleptic properties like color and odor.  
2.1.2Melting points and/or Boiling point: 
Melting points of starting materials (e.g. aniline, 4 methyl 
aniline, 4 chloro aniline, 4 bromo aniline, 4 nitro aniline) 
were determined by using a digital capillary melting point 
apparatus (Cambell Electronics, Bombay, India) by capillary 
fusion method. 
2.1.3 Thin layer chromatography: 
All the starting materials (e.g. aniline, 4 methyl aniline, 4 
chloro aniline, 4 bromo aniline, 4 nitro aniline) were further 
identified and confirmed by Thin Layer Chromatographic 
(TLC) study on readymade TLC plate in Toluene + methanol 
(95:5)V/V mixed solvent system and Rf values were matched 
with earlier reported values [11-12]. 
2.1.4 Ultraviolet spectrum:  
20 mg of all the starting materials were dissolved 
individually in a 100 ml of respective solvent system. Then 
from this solution 10 ml was taken and volume was made up 
to 100 ml with respective solvent system, to make the 
solution concentration of 20µg/ml & the resulting solution 
was scanned between 200-600 nm using UV-Visible 
spectrophotometer (UV-1800, Shimadzu, Tokyo, Japan).
 
 
2.2 Synthesis of Substituted-Indole-2, 3 dione (Isatin) and Final Products: 
 
 
                               
 
      
 
Figure 2: Substituted-1-(4-substituted benzyl) indole-2,3-dione 
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Figure 3: Scheme for synthesis of Substituted-1- (4-substituted benzyl)-1H- indolo (2,3-b) quinoxaline N-benzyl indole-2,3- 
dione from substituted aniline 
Compound R R’ 
QX1 Br F 
QX2 CH3 F 
QX3 CH3 CH3 
QX4 Cl CH3 
QX5 Br CH3 
 
 
2.3 Synthetic Procedure: 
2.3.1 Preparation of substituted isonitroso acetanilide 
from p-substituted aniline: 
100 ml round bottom flask was taken and 3.6 gm (0.05M) of 
chloral hydrate and 48 ml of purified water was taken in it. 
Then 44 gm of crystallized anhydrous sodium sulfate was 
added in it and a solution of substituted aniline (0.05 M) in 
12 ml of water with 1.7 ml (0.052M) of concentrated 
hydrochloric acid was added to dissolve the amine, and 
finally, a solution of 4.5gm (0.158M) of hydroxylamine 
hydrochloride in 20 ml of water. The flask was heated over a 
heating mantle, so that vigorous boiling begins in about 40-
45 minutes. After 1-2 minutes of vigorous boiling the 
reaction completes and during the heating period, some 
crystal of substituted isonitroso acetanilide separates. The 
final solution was cooled down under the running water and 
crystallized material was filtered on suction, and air dried. 
2.3.2 Preparation of substituted isatin from substituted 
isonitroso acetanilide: 
32.5 ml of concentrated sulfuric acid was warmed upto 50C 
in a 100 ml round bottom flask with continuous stirring, and 
7.5 gram of (0.046 M) of dry substituted isonitroso 
acetanilide was added to such a rate that to keep the 
temperature 60-70 but not higher. External cooling was 
applied at this stage to carry out the reactions more rapidly. 
After the addition of the substituted isonitroso acetanilide 
compound was finished, the solution was heated to 80C and 
kept at this temperature for about 10 minutes to complete 
the reaction. Then the reaction mixture was cooled to room 
temperature and poured to 10-12 times its volume of 
cracked ice. After standing for about one and half hour the 
substituted isatin was filtered with suction, washed several 
times to cold water to remove the sulfuric acid, and then 
dried in the air. For purification the dried substituted isatin 
was dissolved in the 50 ml of hot water and suspension was 
made, to this hot reaction mixture added the solution of 
sodium hydroxide (5gm in 10 ml) till the complete 
dissolution of the substituted isatin. The resulting clear 
solution was neutralized slowly with dilute hydrochloric 
acid. Filtered the solution and made the solution acidic with 
the dilute hydrochloric acid. Cooled the solution and the 
crystals of different substituted isatins were separated. 
Filtered the product and dried in oven. The yield values and 
melting points were recorded of different substituted isatins 
like unsubstituted Isatin, 5-Chloro isatin, 5-Bromo isatin, 5-
Methyl isatin and 5-Nitro isatin, and all the values were 
compared with reported values. 
2.3.3 Method of preparation of substituted N-benzyl 
indole-2,3-dione from substituted isatin: 
 In the round bottom flask take indole-2,3-dione (isatin) 
0.00337 M and equimolar quantity of benzyl chloride mixed 
with 20 ml of dimethyl formamide (DMF) and to this mixture 
added 2 gm of potassium carbonate. After gentle mixing of 
this reaction mixture, reflux for 2 hour, cooled and poured to 
100 ml of ice water cold water. The resultant precipitate 
collected washed with water and dried and recrystallised 
from ethanol-water mixture. Dried and checked the melting 
point. 
H2N
H2N
Glacial acetic acid
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2.3.4 Method for preparation of substituted 1-benzyl-1H-
indolo (2,3-b) quinoxaline FROM substituted N-benzyl 
indole-2,3-dione: 
To the orange colored 1- ( 4 - substituted benzyl ) - 1,3 - di 
hydro – indole - 2, 3-dione (1gm) equimolar quantity of 
orthophenylenediamine and 0.50 ml of glacial acetic acid was 
added and refluxed in 100ml of ethanol for two hours on 
water bath. The initial Colored solution slowly changes in to 
some fluffy solid crystals in the end of the reaction, which 
was verified by TLC on silica plates. Excess ethanol was 
removed and after drying, the compound purified by ethanol. 
2.4 Microbiological Evaluation of Final Products:  
All synthesized final products were screened for in vitro 
antibacterial activity [ 13-19, 20-22] against four bacterial 
strains, namely Staphylococcus aureus (MTCC 96), 
Staphylococcus pyogenus, Pseudomonas aeruginosa (MTCC 
1688), Escherichia coli (MTCC 443) and two fungal strains, 
namely Candida albicans (MTCC 227) and Aspergilla niger 
(MTCC 282). 
All those compounds screened for antibacterial activity were 
also tested for their antifungal activity by using Agar 
diffusion cup plate method. The fungi employed for 
screening were: Aspergillus Niger and Candida albicans. All 
compounds subjected for antimicrobial activity was 
performed by two different concentrations and standard 
drugs like Ciprofloxacin and Fluconazole were used for 
comparison purpose respectively.  
2.4.1 Preparation of Culture Media: 
Nutrient broth was used as growth medium for bacteria and 
Saubouraud dextrose broth for fungi. Nutrient broth was 
prepared by dissolving 12gm of dehydrated powder (HI-
media) in 100ml of purified water. Saubouraud dextrose 
broth was prepared by dissolving 4gm of dextrose and 1gm 
of peptone in 100ml of distilled water. The media were 
sterilized by autoclaving at 15lbs pressure for 20 minutes. 
2.4.2 Preparation of Stock Culture: 
Stock cultures were obtained by aseptically transferring a 
loopful of test organisms to 100ml of sterile broth and 
incubated for 24 hours at 370C for bacteria and 240C for 
fungi. 
2.4.3 Standardization of Stock Culture: 
Stock cultures were placed in the incubator (370C for 
bacteria and 240C for fungi) and shaken well. 1ml of stock 
cultures was aseptically transferred to 9 ml of sterile water 
containing 0.05% tween 80. This was mixed with using a 
cyclomixer and serially diluted from 10-1 to 10-10. From 
each dilution, 0.2ml was taken and spread on sterile nutrient 
agar plates for bacteria and Sabouraud dextrose agar plates 
for fungi, which were incubated for 18 hours. After 
incubation, the numbers of colonies in the plate were 
counted. The number of colonies for a plate that was formed 
from the maximum dilute tube was noted. The number of 
microorganisms in stock were then calculated and expressed 
as colony forming units per ml (cfu/ml). By back calculation 
the stock culture was found to contain 15 × 108 cfu/ml. 
2.4.4 Preparation of Working Stock Culture: 
Stock culture (0.1ml) was diluted with nutrient broth 
(100ml) and Sabouraud dextrose broth (100ml) respectively 
to obtain 105 cfu/ml. This was then used for further in vitro 
screening. 
2.4.5 Preparation of Drug Dilutions: 
Solutions of the title compounds in DMSO (1mg/ml) were 
prepared and used for screening their antimicrobial activity. 
2.4.6 Preparation of discs: 
Discs of 5-6 mm in diameter were punched from No. 1 
Whattmann filter paper with sterile cork borer of same size. 
These discs were sterilized by keeping in oven at 140°C for 
60 minutes. Standard and test solutions were added 
separately to these discs which were air dried later on. 
2.4.7 Diffusion Test: 
A filter-paper disk impregnated with the compound to be 
tested was placed on the surface of the agar carefully by 
using sterilized forceps. The compound diffused from the 
filter paper into the agar. The larger the clear area around 
the filter disk, the more effective was regarded the 
compound. These petridishes were kept up to one hour for 
diffusion at room temperature and then for incubation at 
37°C for 24 hours in an incubator. The zones of inhibition 
after 24 hours were measured in millimeters. The size of the 
zone of inhibition was measured as a determination of 
compound's effectiveness. 
2.5 MIC: 
2.5.1 Antimicrobial Screening: 
Synthesized products were subjected to antimicrobial 
screening by estimating the minimum inhibitory 
concentration (MIC) by adopting serial dilution technique. 
Test was carried out on four bacterial strains, namely 
Staphylococcus aureus (MTCC 96), Staphylococcus pyogenus, 
Pseudomonas aeruginosa (MTCC 1688), Escherichia coli 
(MTCC 443) and two fungal strains, namely Candida albicans 
(MTCC 227) and Aspergilla niger (MTCC 282). 
2.5.2 Determination of MIC:  
The study involved a series of six assay tubes for each title 
compound against each microorganism. The entire test was 
done in triplicate. To the first assay tube, 1.8ml of seeded 
broth and 0.2ml of title compound (1mg/ml) was added and 
mixed thoroughly and the two fold serial dilution was done 
up to the sixth tube containing 1 ml of seeded broth. The 
additions of the drug solution and serial dilution were done 
under strict aseptic conditions. Solvent control, negative 
control (growth control) and drug control were maintained 
during the experiment. The assay tubes were incubated at 
370C and 240C respectively for 24 hours for bacteria and 
fungi. The lowest concentration, which apparently caused 
complete inhibition of growth of microorganisms, was 
considered as the minimum inhibitory concentration (MIC).  
3. RESULT AND DISCUSSION: 
3.1 Identification and Characterization of the 
Synthesized Compounds: 
The identification and characterization [8-20] of the 
compound were carried out by the following procedure to 
establish the structure and chemical nature of recently 
synthesized compounds as Physical appearance, Melting 
points & boiling points, Thin layer chromatography, 
Ultraviolet spectrum, FTIR (FT-Infra red spectroscopy), NMR 
(1H NMR, 13C NMR), FAB – MS, Elemental CHN analysis.
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3.2 Identification and Characterization of the Intermediate:  
Table 1: Physical appearance, % yield, and molecular weight with formula of final synthesized compounds 
Sl. 
No. 
Ingredients Compound 
code 
Physical 
appearance 
% Yield Molecular 
Formula 
Molecular 
Weight 
1. 
N
N
N
CH
2
F
Br
 
 
QX1 
 
Yellowish 
solids 
 
83±2.06 
 
C21H13BrFN3 
 
406.13 
2. 
N
N
N
CH
2
F
CH
3
 
 
QX2 
 
Yellowish 
solid 
 
79±3.04 
 
C22H16FN3 
 
341.25 
3. 
N
N
N
CH
2
CH
3
CH
3  
 
QX3 
 
Yellowish 
solid 
 
78±2.46 
 
C23H19N3 
 
337.41 
4. 
N
N
N
CH
2
CH
3
Cl
 
 
QX4 
 
Brownish 
solid 
 
80±3.94 
 
C22H16ClN3 
 
357.82 
5. 
N
N
N
CH
2
CH
3
Br
 
 
QX5 
 
Brownish 
solid 
 
80±4.14 
 
C22H16N3Br 
 
402.28 
 
 
3.3 Microbiological Evaluation: 
3.3.1 Antibacterial activity: 
Table 2: Zone of inhibition of the synthesized compounds 
Compound 
 
 
 
                Bacterial strain 
 
Antibacterial Activity: Zone of inhibition (mm) 
Gm +ve Gm -ve 
Staphylococcus aureus  Staphylococcus 
pyogenes 
Escherichia coli Pseudomonas 
aeruginosa 
Concentration (µg/ml) 
 
 
                              IZ and AI 
100 100 100  
100 
 
IZ 
 
AI 
 
IZ 
 
AI 
 
IZ 
 
AI 
 
IZ 
 
AI 
QX1 24±2 0.89 22±2 0.85 25±3 0.86 26±2 0.96 
QX 2 14±1 0.52 15±1 0.58 16±2 0.55 14±1 0.52 
QX 3 - - - - - - - - 
QX 4 22±2 0.81 18±3 0.69 22±2 0.76 23±3 0.85 
QX 5 20±2 0.74 18±2 0.69 21±2 0.72 22±3 0.81 
Ciprofloxacin  27±3 - 26±3 - 29±4 - 27±4 - 
All values are Mean±SD; n=3; IZ= Inhibition zone in mm (mean value; include 6 mm diameter of disc), AI= Activity Index (IZ 
developed by synthesized compound /IZ developed by standard), (-) = No activity 
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Table 3: Antifungal activity: Zone of inhibition of the synthesized compounds 
Compound 
 
                                               Bacterial strain 
Zone of inhibition: Antifungal activity 
Candida albicans Aspergilla niger 
Concentration (µg/ml) 
 
                                                         IZ and AI 
 
100 
 
100 
IZ AI IZ AI 
QX1 26±4 0.81 14±2 0.88 
QX 2 20±2 0.63 12±1 0.75 
QX 3 - - - - 
QX 4 23±3 0.72 12±1 0.75 
QX 5 22±3 0.69 11±1 0.69 
Fluconazole 32±4 - 16±2 - 
All values are Mean±SD; n=3; IZ= Inhibition zone in mm (mean value; include 6 mm diameter of disc), AI= Activity Index (IZ 
developed by synthesized compound /IZ developed by standard), (-) = No activity 
 
 
 
3.3.2 Determination of MIC:  
Table 4: Antimicrobial activity (MIC) of standard & synthesized compounds containing indole ring 
 
Compound 
 
                       Strain  
Minimal Inhibitory Concentration (µg/ml) 
Antibacterial Activity  
Antifungal activity Gm +ve Gm -ve 
Staphylococcus 
aureus  
Staphylococcus 
pyogenes 
Escherichia 
coli 
Pseudomonas 
aeruginosa 
Candida 
albicans 
Aspergilla 
niger 
QX1 16 14 18 22 28 19 
QX 2 38 36 39 40 55 82 
QX 3 - - - - - - 
QX 4 28 32 33 29 49 63 
QX 5 30 33 35 29 51 64 
Ciprofloxacin 13 12 16 13 NT NT 
Fluconazole NT NT NT NT 25 15 
QX1 QX 2 QX 3 QX 4 QX 5 Ciprofloxacin
Staphylococcus aureus 24 14 0 22 20 27
Staphylococcus pyogenes 22 15 0 18 18 26
Escherichia coli 25 16 0 22 21 29
Pseudomonas aeruginosa 26 14 0 23 22 27
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4. CONCLUSION: 
QX1 was found to exhibits the most potent in-vitro 
antimicrobial activity with the zone Inhibition in mm 24±2 
and activity index 0.89, against Staphylococcus aureus, 22±2 
and 0.85 against Staphylococcus pyogenes, 26±2 and 0.96 
against Pseudomonas aeruginos, 25±3 and 0.86 against 
Escherichia coli and two fungal strains shown 26±4 and 0.81 
against Candida albicans and 14±2 & 0.88 against Aspergilla 
niger respectively. These compounds were screened for their 
antibacterial activity. The minimum inhibitory 
concentrations (MICs) of the compounds were determined 
by agar streak or adopting serial dilution method. Among the 
synthesized compounds; QX1 was found to exhibits the most 
potent in-vitro antimicrobial activity with the MICs of 16, 14, 
22 and 18 μg/ml against Staphylococcus aureus, 
Staphylococcus pyogenes, Pseudomonas aeruginosa, and 
Escherichia coli respectively. Compound Bromo-1-(4-fluro  
methyl benzyl)-1H-indolo (2,3-b) quinoxaline N-benzyl 
indole-2,3-dione (QX1) was found to exhibit the most potent 
in-vitro anti-fungal activity with MICs value of 28 and  19 
μg/ml against Candida albicans  and Aspergilla niger. All 
substituted quinoxaline compounds have been screened for 
their antimicrobial activity. From the screening results it was 
observed that the presence of electron withdrawing group (-
F, Br, Cl) made the substituted quinoxaline compounds to 
exhibit moderate to significant antibacterial and antifungal 
activity in comparison to standard drug ciprofloxacin and 
fluconazole respectively. Compound QX1 and QX4 exhibited 
promising antibacterial and antifungal activity. However 
other two compounds (QX5 & QX2) of the series also 
exhibited moderate to weak activity against the 
microorganisms. 
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